http://www.pumabiotechnology.com
Puma Biotechnology, Inc. Company Intro
Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of cancer. Cougar was acquired by Johnson & Johnson in July 2009 for approximately $1 billion.
Industry
Healthcare
Puma Biotechnology, Inc. Headquaters
10880 Wilshire Boulevard
Los Angeles,90024
United States
Puma Biotechnology, Inc. Share price
14 Sep 2022 09:59 GMT
$2.6000
-0.11 (-4.06 %)
Puma Biotechnology, Inc. Market cap
$112.435 M
WMC RANKING
2023
Puma Biotechnology, Inc. # 31
BiotechnologyLatest Puma Biotechnology, Inc. News
27 Jan 2023
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above ...
Puma Biotechnology, Inc, a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States...
27 Jan 2023
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above ...
Puma Biotechnology, Inc, a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States...
25 Jan 2023
Before You Invest In Puma Biotechnology Inc. (NASDAQ:PBYI ...
In yesterday's Wall Street session, Puma Biotechnology Inc. (NASDAQ:PBYI) shares traded at $4.56, up 2.47% from the previous session.
WMC Market Score
WMC Market to Revenue Score
Puma Biotechnology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Puma Biotechnology, Inc. | USD | $272,062 | $208,212 | $-26,534 | $1,124M | 31 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Puma Biotechnology, Inc. Social Followers vs Top 4 Industry Competitors
Puma Biotechnology, Inc. Post vs Top 4 Industry Competitors
Puma Biotechnology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Puma Biotechnology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Puma Biotechnology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Puma Biotechnology, Inc. | 2.96 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
